Agenus

Agenus is a clinical-stage immunotherapy company dedicated to harnessing the power of the immune system to fight cancer. They develop a comprehensive pipeline of immunological agents, including checkpoint inhibitors, immune activators, and tumor microenvironment conditioning agents. Agenus’ vision is to expand the patient populations benefiting from cancer immunotherapy through combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies, and adjuvants.

Agenus has a robust internal clinical research capability, state-of-the-art GMP manufacturing facilities, and a global reach with offices in the US and Europe. They have brought together top talent and expertise to advance their mission, building a team of over 400 employees across their offices. Agenus is committed to making their investigational therapies available to patients with cancer and is actively exploring accelerated approval strategies for their lead product candidates.

Agenus offers flexible work arrangements, including both in-person and remote options, allowing employees to work collaboratively across 11 time zones. Their global reach and diverse work structure encourage flexibility and empower employees to tailor their work schedule and environment to fit their needs, whether they prefer working in person, remotely, or a combination of both.

Agenus offers a comprehensive benefits package that includes flexible vacation time for employees to prioritize their well-being, financial planning support through 401(k) contributions and other programs, and a focus on employee wellness through customized support programs. Their commitment to a diverse workplace is demonstrated through engagement groups focused on inclusion and leadership, and they also provide educational assistance, leadership forums, and competitive health plans with options for telehealth and care.com memberships to support both professional and personal development.

Agenus is a clinical-stage immunotherapy company committed to harnessing the power of the immune system to develop therapies with curative intent for individuals living with cancer. Their mission is to expand the patient population benefiting from immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies, and adjuvants.

Agenus promotes a culture of boldness, innovation, and collaboration. They encourage employees to challenge conventional standards, work as a global team, and be deeply committed to learning. They are passionate about their mission to find a cure for cancer and put the patient first in everything they do. This is reflected in their commitment to providing employees with flexible vacation time, wellness programs, and development opportunities, as well as their focus on building a diverse and inclusive workplace.

Agenus prioritizes diversity, equity, and inclusion as core values, fostering a global team where employees are empowered to make a difference in the lives of cancer patients. They strive for a workplace that is inclusive and diverse, reflecting their global reach and commitment to collaboration. Agenus encourages an environment where individuals feel valued, respected, and empowered to contribute their unique perspectives and talents, ultimately driving innovation in cancer therapy.